Tommy Pham
Physician Assistant · Whittier, CANPI 1447930110
Payments from drug & device makers
Across 160 payments — averaging $24.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$481
- Novo Nordisk$376
- Mannkind Corporation$300
- Amgen$285
- Recordati_rare_diseases_inc.$255
- Boehringer Ingelheim$225
- plus $2K from 32 others
What the payments were for
- Travel & lodging$602%
- Food & beverage$3,84398%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 23 | $481 |
| Novo Nordisk | 15 | $376 |
| Mannkind Corporation | 14 | $300 |
| Amgen | 8 | $285 |
| Recordati_rare_diseases_inc. | 5 | $255 |
| Boehringer Ingelheim | 9 | $225 |
| Medtronic | 6 | $222 |
| Antares Pharma, Inc. | 12 | $198 |
| AbbVie | 10 | $174 |
| IBSA Pharma Inc. | 4 | $164 |
| Insulet Corporation | 6 | $135 |
| Bayer | 4 | $107 |
| Novartis | 3 | $77 |
| Radius Health, Inc. | 3 | $74 |
| Tandem Diabetes Care, Inc. | 3 | $70 |
| AstraZeneca | 2 | $66 |
| Xeris Pharmaceuticals, Inc. | 3 | $66 |
| Cequr Corporation | 2 | $54 |
| Kyowa Kirin, Inc. | 2 | $52 |
| Sanofi-aventis U.S. LLC | 2 | $51 |
| Corcept Therapeutics | 2 | $50 |
| Ascendis Pharma Endocrinology Inc | 2 | $45 |
| Ascensia Diabetes Care US Inc. | 2 | $43 |
| Sequel Med Tech, LLC | 2 | $39 |
| Tolmar, Inc. | 2 | $34 |
| Amphastar Pharmaceuticals, Inc. | 2 | $34 |
| Rhythm Pharmaceuticals, Inc. | 1 | $31 |
| Averitas Pharma Inc. | 1 | $28 |
| Neurocrine Biosciences, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $18 |
| BETA Bionics, Inc. | 1 | $16 |
| Globus Medical | 1 | $15 |
| GSK | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Alvogen Inc | 1 | $13 |
| Abbott | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,903 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 73 | $114,344 |
| TrulicityDulaglutide | 64 | $91,848 |
| MounjaroTirzepatide | 43 | $54,262 |
| JardianceEmpagliflozin | 34 | $44,209 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 32 | $26,856 |
| FarxigaDapagliflozin Propanediol | 18 | $24,417 |
| JanuviaSitagliptin Phosphate | 19 | $20,395 |
| InvokanaCanagliflozin | 15 | $10,596 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $6,951 |
| MyrbetriqMirabegron | 12 | $5,414 |
| Humalog Kwikpen U-100Insulin Lispro | 14 | $3,216 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 35 | $2,947 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 14 | $2,241 |
| HumalogInsulin Lispro | 16 | $2,013 |
| SynthroidLevothyroxine Sodium | 20 | $1,730 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $481 | $148,123123 claims |
| Novo NordiskOzempic | $376 | $114,34473 claims |
| Boehringer IngelheimJardiance | $225 | $44,20934 claims |
| AstraZenecaFarxiga | $66 | $24,41718 claims |
| AbbVieSynthroid | $174 | $1,73020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Whittier
- Erin BoriniWhittier$59K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.